Manuel Carrondo is Vice President, iBET and a professor in Chemical and Biochemical Engineering, Faculty of Sciences and Technology, University Nova de Lisboa. He is also the founder (1988) and earlier president and CEO (currently Vice-President) of IBET. Over the course of his career he has been member and Vice- Chairman of the External Advisory Group Cell Factory (Research Directorate General, European Commission) (1998-2002), CEVEC Pharmaceuticals, Kln (2007-2017), PBS Biotech, California (2009-), CNIC - Spanish National Center for Cardiovascular Research Carlos III, Spain (2011-2015), Masthercells - Manufacturing Synergies for Therapeutic Cells, Belgium (2012-2016), Nanotechnology and Converging Technologies - (2014-2018), iNOVA4Health - Advancing Precision Medicine, Portugal, Unit Coordinator (2015-), IBMT - Fraunhofer Institute for Biomedical Engineering, St. Ingbert, Germany and Max Planck Inst. Dynamics Complex Technical Systems, Magdeburg (2008-2013). Manuel has supervised thirty-four Ph.D. students and has published over two hundred and forty papers in refereed international journals; he was also Associate-Editor of Journal of Biotechnology (2000-2017), editorial board member of Biotechnology and Bioengineering, Current Gene Therapy and Biotechnology Letters; referee of Biotechnology Progress, Cytotechnology, Applied Microbiology and Biotechnology, and Enzyme and Microbial Biotechnology.